Balance Sheet

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Others

Cognex (CGNX) Asset Writedowns and Impairment (2020)

Cognex filings provide 3 years of Asset Writedowns and Impairment readings, the most recent being $19.6 million for Q2 2020.

On a quarterly basis, Asset Writedowns and Impairment changed N/A to $19.6 million in Q2 2020 year-over-year; TTM through Jul 2021 was $19.6 million, a 0.0% change, with the full-year FY2020 number at $19.6 million, changed N/A from a year prior.
Asset Writedowns and Impairment hit $19.6 million in Q2 2020 for Cognex, up from $148000.0 in the prior quarter.
In the past five years, Asset Writedowns and Impairment ranged from a high of $19.6 million in Q2 2020 to a low of $19.6 million in Q2 2020.